Intestinal ischemia-reperfusion (I/R) causes gut dysfunction characterized by decreased basement membrane integrity and decreased barrier function. Indeed, it has been reported that the absorption of several drugs is altered after intestinal I/R. Intestinal I/R also promotes multi-organ failure (MOF). The liver and kidney can be affected by MOF after intestinal I/R. However, little is known about the alteration of pharmacokinetics after intravenous administration in intestinal I/R injury. In the present study, we investigated pharmacokinetics of digoxin after oral administration and intravenous administration in intestinal I/R injury. Plasma digoxin concentration in I/R rats after oral administration was not significantly altered at any time compared with that in sham-operated rats. Plasma digoxin concentration in rats reperfused for 1 h after intravenous administration was significantly higher than that in sham-operated rats. Plasma digoxin concentrations in rats reperfused for 6 and 24 h were the same as those in sham-operated rats. The area under the concentration-time curve after intravenous administraion (AUC i.v. ) and total clearance (CL tot ) in rats reperfused for 1 h was 1.89-and 0.57-fold higher than that in sham-operated rats. However, elimination rate (k e ) and half-life (t 1/2 ) in rats reperfused for 1 h were not altered. Distribution volume (V d ) in rats reperfused for 1 h was decreased than that in sham-operated rats, but there was not statistical difference. These results suggest that intestinal I/R affected the V d of digoxin, and plasma concentration of digoxin was increased. The present study suggests that understanding pharmacokinetics of drug after intravenous administration in intestinal I/R injury is important to provide valuable information for safe drug therapy for intestinal I/R patients.
Intestinal ischemia-reperfusion (I/R) is a common clinical problem in the settings of small bowel transplantation, circulatory shock and strangulation ileus. Intestinal I/R causes gut dysfunction characterized by histological evidence of mucosal injury, decreased basement membrane integrity and decreased barrier function. 1) Although the molecular details underlying the mechanisms of acute intestinal injury and repair after I/R have not been completely elucidated, it is known that reactive oxygen species (ROS) play a role in acute intestinal injury after I/R. 2) Decreases in basement membrane integrity and barrier function of the intestine promote not only bacterial invasion but also permeation of compounds, including drugs. Indeed, it has been reported that the absorption of several drugs is altered after intestinal I/R. [3] [4] [5] Furthermore, decreased basement membrane integrity and barrier function of the intestine promote local production of inflammatory cytokines. 6) Therefore, intestinal I/R promotes inflammation and multi-organ failure (MOF). 7) The liver and kidney can be affected by MOF after intestinal I/R. In the liver, sinusoidal and venular endothelial cell damage causes loss of hepatic vascular permeability barrier function. 8) In addition, the levels of aspartate (AST) and alanine (ALT) transaminase in serum are significantly increased after intestinal I/R. 9) In the kidney, the most prominent changes are swelling of endothelial cells and destruction of mitochondrial cristae in endothelial cells of glomerular capillaries and epithelial tubular cells.
10) It has also been shown that blood urea nitrogen (BUN) increases and that inulin clearance decreases after intestinal I/R. 11, 12) However, little is known about the alteration of pharmacokinetics after intravenous administration in intestinal I/R injury. In the present study, we investigated pharmacokinetics of digoxin after oral administration and intravenous administration in intestinal I/R injury. Animals Male Wistar rats, aged 6 weeks, were obtained from Jla (Tokyo, Japan). The rats were housed for at least 1 week (until reaching 250-350 g in weight). The housing conditions were the same as those described previously. 13) The experimental protocols were reviewed and approved by the Hokkaido University Animal Care Committee in accordance with the "Guide for the Care and Use of Laboratory Animals."
MATERIALS AND METHODS

Chemicals
Intestinal I/R Model Surgical procedures were carried out as described in a previous report with some modification. 14) Rats were not fed for 16 h prior to the experiments but were allowed free access to water. The animals were anesthetized with sodium pentobarbital (30 mg/kg body weight, intraperitoneal (i.p.) injection). Through a midline laparotomy, each rat was subjected to 30 min of ischemia by ligating small anastomosing vessels and occluding the superior mesenteric artery (SMA), and reperfusion was induced by removing the clamp. The abdomen was then covered with a sterile plastic wrap.
Transport Experiments The intestine was quickly removed and the longitudinal muscle layer was carefully stripped off with scissors. Prepared intestinal sheets were filled with Hanks' balanced salt sodium (HBSS) buffer (137 mM NaCl, 5.4 mM KCl, 1.0 mM CaCl 2 , 0.8 mM MgCl 2 , 0.4 mM KH 2 PO 4 , 0.3 mM NaH 2 PO 4 and 25 mM D-glucose). The pH of the buffer was adjusted to 6.0 or 7.4 with 1 N HCl or NaOH. The prepared intestinal sheets were mounted between two Ussing-type diffusion chambers (Corning Costar Corporation, Cambridge, MA, U.S.A.) that provided an exposed area of 0.64 cm 2 . HBSS buffer was added to the chambers of the mucosal and serosal sides. The volume of bathing solution on each side was 1.5 ml, and the solution temperature was maintained at 37°C in a water-jacketed reservoir. The solution was bubbled with a 95 : 5 mixture of O 2 /CO 2 before and during the transport experiment. The buffer solution in one of the chambers contained a substrate. Samples of 0.5 ml were taken from the receptor side at 30, 60, 90 and 120 min after incubation. A scintillation spectrometer (1600TR, Packard Instruments, Meriden, CT, U.S.A.) was used to measure D-
3 H]-mannitol was expressed as an apparent permeability coefficient (P app ) according to the following equation: P app ϭdQ/dt/SC 0 , where dQ/dt is the linear appearance rate of mass in the receiver solution, S is the exposed area (0.64 cm 2 ) , and C 0 is the initial concentration of
]-mannitol (500 mM). P app is expressed in centimeters per minute.
Measurement of Transepithelial Electrical Resistance (TEER)
The TEER values of the intestinal membranes were measured by an in vitro diffusion chamber method using stripped rat intestinal membranes. 15) After surgical operation, the small intestine was isolated and the intestinal segments were mounted in a diffusion chamber in which a surface area of 0.64 cm 2 . Two pairs of electrodes connected to a Millicell-ERS (Nihon Millipore K.K., Tokyo, Japan) were inserted into each side of the diffusion chamber, respectively. Phosphate buffer saline (PBS) 2.25 ml was added to the each side. TEER values were calculated by the following equation: TEERϭresistance value (W)ϫsurface area (cm 2 ). Administration of Digoxin Experiment Digoxin suspension (0.25 mg/ml) was orally administered at 0.25 mg/kg body weight. The volume of digoxin suspension was 1 ml/kg body weight. Blood samples (each 0.4 ml) were collected into tubes from a cervical vein at 20, 40, 60, 90, 120 and 180 min after oral administration of digoxin. Digoxin solution (10 mg/ml) was intraveneously administered at 10 mg/kg body weight. The volume of digoxin solution was 1 ml/kg body weight. Blood samples (each 0.4 ml) were collected into tubes from a cervical vein at 5, 10, 30, 60 and 120 min after intravenous administration of digoxin. Following centrifugation (850ϫg for 15 min at 4°C), the plasma was diluted to a concentration in the range of 0.5 to 4.5 ng/ml. A TDxFLx analyzer (Abbott Japan CO., LTD., Tokyo, Japan) was used to measure dilute plasma concentration of digoxin. The standard curve was established by digoxin calibrators (Abbott Japan CO., LTD., Tokyo, Japan). The concentration range of the standard curve is 0-5.0 ng/ml. The correlation coefficient for the standard curves is 0.995Ϯ0.003. The area under the concentration-time curve (AUC) of digoxin was calculated using the trapezoidal rule from the concentrationtime curve. Total clearance (CL tot ) was calculated by the following equation: CL tot ϭD/AUC, where D is the dosage amount. The elimination rate constant (k e ) was calculated by the following equation: ln CϭϪk e tϩln C 0 , where C is plasma concentration. The half-life (t 1/2 ) was calculated by the following equation: t 1/2 ϭln 2/k e . The distribution volume (V d ) was calculated by the following equation:
Data Analysis Statistical significance was evaluated using unpaired Student's t-test. A value of pϽ0.05 was considered significant.
RESULTS AND DISCUSSION
Decreasing basement integrity is often assessed by the amount of mannitol or dextran permeation through the intestinal membrane. [16] [17] [18] Mucosal to serosal flux for mannitol was calculated from the linear serosal radioisotope appearance curves. P app of mannitol through intestinal membranes of rats reperfused for 1 h was significantly higher than that of mannitol through intestinal membranes of sham-operated rats (Fig. 1A) . P app s of mannitol through intestinal membranes of rats reperfused for 6 h and 24 h were almost the same as those in sham-operated rats. The viability of the intestinal membrane was maintained during the experiments (data not shown). The TEER value of intestinal membrane of rats reperfused for 1 h was significantly decreased (Fig. 1B) .
The TEER values of intestinal membrane of rats reperfused for 6 h and 24 h were almost the same as those of sham-operated rats. These results indicated that barrier function of the intestinal membrane and tight junction in the intestine were damaged at 1 h after I/R and were recovered at 24 h after I/R. These results are associated with results of histological features of the intestine. 19) Next, we performed an in vivo oral and intravenous administration study using digoxin. Digoxin is a typical substrate of P-gylcoprotein (P-gp) as is tacrolimus. Omae et al. reported that plasma concentration of tacrolimus after oral administration was affected by enhanced P-gp function in the ileum after intestinal I/R. 19) Figure 2 shows the time courses of plasma digoxin concentration after oral administration at a dose of 0.25 mg/kg. Plasma digoxin concentration in I/R rats was not significantly altered at any time compared with that in sham-operated rats. At 1 h after intestinal I/R, the absorption of digoxin was not affected by intestinal I/R, although the permeability of mannitol through the intestinal membrane was increased. Digoxin (log Pϭ1.26, 20) where P is octanol/water partition coefficient) is more hydrophobic compound than mannitol (log PϭϪ3. 10 21) ). This hydrophilic/hydrophobic difference between these compounds may affect the permeability through the intestinal membrane. The paracellular pathway to the lateral intercellular space via tight junctions between epithelial cells is a passive transport for many water-soluble and poorly lipid-soluble compounds. As shown in Fig. 1B , tight junction in the intestine after intestinal I/R was maintained about 80%, although tight junction in intestinal I/R rats was significantly weak compared with that in sham-operated rats. Therefore, we suggest that the permeability of digoxin, which is more hydrophobic compound, through the intestinal membrane was not affected by intestinal I/R. At 24 h after intestinal I/R, plasma concentration of tacrolimus after oral administration was significantly decreased. 19) However, plasma concentration of digoxin was not altered. The reason of the difference between digoxin and tacrolimus is still not clear. Intestinal I/R is known to affect the kidney and liver as well as the intestine. [8] [9] [10] [11] [12] Next, we investigated whether the pharmacokinetics of digoxin is affected by intestinal I/R. Figure 3 shows the time courses of plasma digoxin concentration after intravenous administration at a dose of 10 mg/kg. Plasma digoxin concentration in rats reperfused for 1 h was significantly higher than that in sham-operated rats. Plasma digoxin concentrations in rats reperfused for 6 and 24 h were the same as those in sham-operated rats. AUC i.v. and CL tot in rats reperfused for 1 h were 1.89-and 0.57-fold higher than that in sham-operated rats (AUC i.v. ϭ541.3Ϯ 92.4 ng/ml/min and CL tot ϭ4.55Ϯ1.04 ml/min in rats reperfused for 1 h vs. AUC i.v. ϭ287.05Ϯ85.8 ng/ml/min and CL tot ϭ 8.01Ϯ1.79 ml/min in sham-operated rats, pϽ0.05 and pϽ0.05). However, k e and t 1/2 in rats reperfused for 1 h were not different compared with sham-operated rats (k e ϭ 0.78Ϯ0.06 h Ϫ1 and t 1/2 ϭ53.5Ϯ4.4 min in rats reperfused for 1 h vs. k e ϭ0.80Ϯ0.16 h Ϫ1 and t 1/2 ϭ54.0Ϯ12.5 min in shamoperated rats, pϭ0.87 and pϭ0.95). V d in rats reperfused for 1 h was decreased than that in sham-operated rats, but there was not statistical different (V d ϭ341.5Ϯ59.0 ml in rats reperfused for 1 h vs. V d ϭ593.2Ϯ179.2 ml in sham-operated rats, pϭ0.07). These results suggest that intestinal I/R affected the V d of digoxin, and plasma concentration of digoxin was increased. It has been reported that absorption of several drugs is affected by intestinal I/R because intestinal I/R induces decrease in barrier function in the intestine, alteration of transporter function and alteration of metabolism enzyme function. Pharmacokinetics of drugs after intestinal I/R was also altered after oral administration. However, it has almost not investigated excretion of drugs and pharmacokinetics of drugs after intravenous administration after intestinal I/R. The present study suggests that understanding pharmacokinetics of drug after intestinal I/R is important to provide valuable information for safe drug therapy for intestinal I/R patients.
In summary, we investigated pharmacokinetics of digoxin after intestinal I/R. Although plasma concentration of digoxin after oral administration was not altered by intestinal I/R, that after intravenous administration was significantly increased at 1 h after intestinal I/R. The increasing of plasma concentration of digoxin was caused by the decreasing V d . These results imply that understanding pharmacokinetics of drugs after intravenous administration, as well as that after oral administration is important for safe drug therapy for intestinal I/R patients. Further study is needed to assess the transporters and the metabolism enzyme function and basement membrane integrity not only in the intestine but also in remote organs, including the kidney and liver. 
